FMP
NASDAQ
0.95 USD
0.08 (8.42%)
Dr. Michael Myers Ph.D.
Healthcare
Biotechnology
https://quoinpharma.com
NASDAQ
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
0001671502
US74907L3006
74907L102
42127 Pleasant Forest Court
703 980 4182
US
4
Aug 1, 2016
0001671502
NASDAQ
Biotechnology
Healthcare
74907L102
US74907L3006
US
0.95
2.12
617.06k
900.13k
-
0.8-12.0
2.67
-
-
-
-
-0.1
-
https://quoinpharma.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.